-
Something wrong with this record ?
Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine
V. Nerandzic, P. Mrozkova, P. Adamek, D. Spicarova, I. Nagy, J. Palecek,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1968 to 1 year ago
PubMed Central
from 1968 to 2020
Europe PubMed Central
from 1968 to 1 year ago
Medline Complete (EBSCOhost)
from 2002-01-01 to 1 year ago
Wiley Free Content
from 1997 to 1 year ago
PubMed
28476070
DOI
10.1111/bph.13849
Knihovny.cz E-resources
- MeSH
- Posterior Horn Cells drug effects metabolism MeSH
- Phosphatidylethanolamines chemical synthesis chemistry pharmacology MeSH
- Mass Spectrometry MeSH
- Carrageenan MeSH
- Rats MeSH
- Spinal Cord drug effects metabolism MeSH
- Synaptic Transmission drug effects MeSH
- Rats, Wistar MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Inflammation chemically induced metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND AND PURPOSE: Endocannabinoids play an important role in modulating spinal nociceptive signalling, crucial for the development of pain. The cannabinoid CB1 receptor and the TRPV1 cation channel are both activated by the endocannabinoid anandamide, a product of biosynthesis from the endogenous lipid precursor N-arachidonoylphosphatidylethanolamine (20:4-NAPE). Here, we report CB1 receptor- and TRPV1-mediated effects of 20:4-NAPE on spinal synaptic transmission in control and inflammatory conditions. EXPERIMENTAL APPROACH: Spontaneous (sEPSCs) and dorsal root stimulation-evoked (eEPSCs) excitatory postsynaptic currents from superficial dorsal horn neurons in rat spinal cord slices were assessed. Peripheral inflammation was induced by carrageenan. Anandamide concentration was assessed by mass spectrometry. KEY RESULTS: Application of 20:4-NAPE increased anandamide concentration in vitro. 20:4-NAPE (20 μM) decreased sEPSCs frequency and eEPSCs amplitude in control and inflammatory conditions. The inhibitory effect of 20:4-NAPE was sensitive to CB1 receptor antagonist PF514273 (0.2 μM) in both conditions, but to the TRPV1 antagonist SB366791 (10 μM) only after inflammation. After inflammation, 20:4-NAPE increased sEPSCs frequency in the presence of PF514273 and this increase was blocked by SB366791. CONCLUSIONS AND IMPLICATIONS: While 20:4-NAPE treatment inhibited the excitatory synaptic transmission in both naive and inflammatory conditions, peripheral inflammation altered the underlying mechanisms. Our data indicate that 20:4-NAPE application induced mainly CB1 receptor-mediated inhibitory effects in naive animals while TRPV1-mediated mechanisms were also involved after inflammation. Increasing anandamide levels for analgesic purposes by applying substrate for its local synthesis may be more effective than systemic anandamide application or inhibition of its degradation. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035610
- 003
- CZ-PrNML
- 005
- 20191010111613.0
- 007
- ta
- 008
- 191007s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/bph.13849 $2 doi
- 035 __
- $a (PubMed)28476070
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Nerandzic, Vladimir $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
- 245 10
- $a Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine / $c V. Nerandzic, P. Mrozkova, P. Adamek, D. Spicarova, I. Nagy, J. Palecek,
- 520 9_
- $a BACKGROUND AND PURPOSE: Endocannabinoids play an important role in modulating spinal nociceptive signalling, crucial for the development of pain. The cannabinoid CB1 receptor and the TRPV1 cation channel are both activated by the endocannabinoid anandamide, a product of biosynthesis from the endogenous lipid precursor N-arachidonoylphosphatidylethanolamine (20:4-NAPE). Here, we report CB1 receptor- and TRPV1-mediated effects of 20:4-NAPE on spinal synaptic transmission in control and inflammatory conditions. EXPERIMENTAL APPROACH: Spontaneous (sEPSCs) and dorsal root stimulation-evoked (eEPSCs) excitatory postsynaptic currents from superficial dorsal horn neurons in rat spinal cord slices were assessed. Peripheral inflammation was induced by carrageenan. Anandamide concentration was assessed by mass spectrometry. KEY RESULTS: Application of 20:4-NAPE increased anandamide concentration in vitro. 20:4-NAPE (20 μM) decreased sEPSCs frequency and eEPSCs amplitude in control and inflammatory conditions. The inhibitory effect of 20:4-NAPE was sensitive to CB1 receptor antagonist PF514273 (0.2 μM) in both conditions, but to the TRPV1 antagonist SB366791 (10 μM) only after inflammation. After inflammation, 20:4-NAPE increased sEPSCs frequency in the presence of PF514273 and this increase was blocked by SB366791. CONCLUSIONS AND IMPLICATIONS: While 20:4-NAPE treatment inhibited the excitatory synaptic transmission in both naive and inflammatory conditions, peripheral inflammation altered the underlying mechanisms. Our data indicate that 20:4-NAPE application induced mainly CB1 receptor-mediated inhibitory effects in naive animals while TRPV1-mediated mechanisms were also involved after inflammation. Increasing anandamide levels for analgesic purposes by applying substrate for its local synthesis may be more effective than systemic anandamide application or inhibition of its degradation. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a karagenan $7 D002351
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a zánět $x chemicky indukované $x metabolismus $7 D007249
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a hmotnostní spektrometrie $7 D013058
- 650 _2
- $a fosfatidylethanolaminy $x chemická syntéza $x chemie $x farmakologie $7 D010714
- 650 _2
- $a buňky zadních rohů míšních $x účinky léků $x metabolismus $7 D020671
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a mícha $x účinky léků $x metabolismus $7 D013116
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a nervový přenos $x účinky léků $7 D009435
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mrozkova, Petra $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Adamek, Pavel $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Spicarova, Diana $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Nagy, Istvan $u Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer Imperial College London, Faculty of Medicine, Chelsea and Westminster Hospital, London, UK.
- 700 1_
- $a Palecek, Jiri $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
- 773 0_
- $w MED00009383 $t British journal of pharmacology $x 1476-5381 $g Roč. 175, č. 12 (2018), s. 2322-2336
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28476070 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191010112032 $b ABA008
- 999 __
- $a ok $b bmc $g 1452270 $s 1074160
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 175 $c 12 $d 2322-2336 $e 20170611 $i 1476-5381 $m British journal of pharmacology $n Br J Pharmacol $x MED00009383
- LZP __
- $a Pubmed-20191007